Authors
Amit Kaura, Ahran Arnold, Vasileios Panoulas, Ben Glampson, Jim Davies, Abdulrahim Mulla, Kerrie Woods, Joe Omigie, Anoop D Shah, Keith Channon, Jonathan N Weber, Mark R Thursz, Paul Elliott, Harry Hemingway, Bryan Williams, Folkert Asselbergs, Michael O’Sullivan, Graham Lord, Narbeh Melikian, David Lefroy, Daryl Francis, Ajay Shah, Divaka Perera, Rajesh Kharbanda, Riyaz Patel, Jamil Mayet
Publication date
2019/5/1
Source
Heart
Volume
105
Issue
Suppl 6
Pages
A26-A27
Publisher
BMJ Publishing Group Ltd and British Cardiovascular Society
Description
Background
Patients presenting with atrial fibrillation (AF) often undergo measurement of troponin level, but interpretation of the result is impeded by uncertainty around its clinical importance. Although coronary artery disease (CAD) has been implicated in the prognostic significance of troponin levels in AF, the role of investigating for CAD and its effect on mortality remain unclear. We investigated the relationship between troponin level, coronary angiography and all-cause mortality in real-world patients presenting with AF.
Methods
We utilised National Institute for Health Research Health Informatics Collaborative data to identify patients admitted between 2010 and 2017 at 5 tertiary centres with a primary diagnosis of AF who underwent at least one troponin measurement. Patients meeting the eligibility criteria were followed up using routinely collected data, until death or censoring in April 2017. The peak troponin …
Total citations